Status:

UNKNOWN

Study the Impact of Hirsutella Sinensis Nutrient Supplements Has on Improving Muscle Health and Metabolism in Elderly

Lead Sponsor:

Chang Gung Memorial Hospital

Collaborating Sponsors:

Grape King Bio Ltd.

Conditions:

Sarcopenia

Old Age; Debility

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

Sarcopenia has now been officially recognized as a muscle disease related to aging, which may increase the risk of falls and fractures and both heart and respiratory diseases in the elderly. Sarcopeni...

Detailed Description

In 1988, Irwin Rosenberg first proposed the term "Sarcopenia" for sarcopenia, which refers to the amount of muscle loss with age. In 2007, the European Working Group on Sarcopenia in Older People (EWG...

Eligibility Criteria

Inclusion

  • To be eligible for inclusion, each participant must fulfill all of the following criteria:
  • Age \>50 years old.
  • Negative pregnancy test for women of childbearing potential.
  • Ability to understand and willingness to be enrolled in our study and sign a written informed consent document

Exclusion

  • Participant who has any of the following criteria will be excluded from the trial:
  • Physical or mental inability.
  • Body mass index (BMI) \> 35 kg/m2
  • Participants have acute medical conditions (such as bacterial or viral infection or active cardiopulmonary disease) that may be incapable of having regular image study.
  • Participants are under regular steroid or hyperthyroid medications, which may have great impact on the whole-body metabolism.
  • Participants are under-nutrient, and they need to have regular liquid oral nutrition formulas support.
  • Participants not expecting to comply with follow up.
  • Received barium study within a week
  • Participants allergic or unable ingest Hirsutella Sinensis nutrient supplement

Key Trial Info

Start Date :

February 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 15 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05284149

Start Date

February 15 2022

End Date

February 15 2024

Last Update

March 17 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chang Gung Memorial Hospital, Keelung Branch

Keelung, Taiwan, 204